Dr Reddy's Laboratories becomes the first and only Indian pharma company on the S&P Dow Jones Sustainability World Index for 2023. The company also retains its position on the Dow Jones Sustainability Index for Emerging Markets for the eighth consecutive year. Dr Reddy's achieved high rankings and scores in the S&P Global Corporate Sustainability Assessment, S&P Global ESG score, and S&P Global CSA 1. Additionally, the company receives the gold medal status from EcoVadis for its sustainability performance.